LB-P3

N/A

Report date: 2023/02/19 23:42:26

Base Information

Drug NameLB-P3
Drug Alias NameLBP3
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionBacteria replacementsMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLISCure Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesLISCure Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A